Texas' effort to launch clinical trials for ibogaine, an experimental treatment for PTSD and other mental health conditions, is getting a boost after President Donald Trump's new executive order to fast-track research on psycedelics, according to ...

President Donald Trump signed an executive order fast-tracking psychedelic drug research after a text exchange with Joe Rogan, targeting treatments for veterans with PTSD.

The deals keep rolling in, with Lilly penning a $7 billion pact for gene delivery biotech Kelonia Therapeutics and UCB taking over cell therapy-focused Neurona Therapeutics; President Trump signed a new executive order supporting the development of psychedelic therapies,

President Trump has signed an executive order to make certain psychedelic drugs more available to treat mental health conditions, such as depression and anxiety. He directed $50 million in federal funds to make them more accessible,

A psychiatrist explains the benefits and risks.

Use of the illicit drug has plummeted in recent years among gen Zers, compared with their parents’ generation

Health officials’ eagerness to advance unproven treatments like peptides and ibogaine sharply contrasts with their skepticism of vaccines, health experts say.